Your browser doesn't support javascript.
loading
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium.
Maillard, Pauline; Hillmer, Laura J; Lu, Hanzhang; Arfanakis, Konstantinos; Gold, Brian T; Bauer, Christopher E; Kramer, Joel H; Staffaroni, Adam M; Stables, Lara; Wang, Danny J J; Seshadri, Sudha; Satizabal, Claudia L; Beiser, Alexa; Habes, Mohamad; Fornage, Myriam; Mosley, Thomas H; Rosenberg, Gary A; Singh, Baljeet; Singh, Herpreet; Schwab, Kristin; Helmer, Karl G; Greenberg, Steven M; DeCarli, Charles; Caprihan, Arvind.
Affiliation
  • Maillard P; Department of Neurology University of California Davis California USA.
  • Hillmer LJ; Department of Neurology University of New Mexico Albuquerque New Mexico USA.
  • Lu H; Department of Radiology Johns Hopkins University School of Medicine Baltimore Maryland USA.
  • Arfanakis K; Department of Biomedical Engineering Illinois Institute of Technology Chicago Illinois USA.
  • Gold BT; Rush Alzheimer's Disease Center Department of Diagnostic Radiology and Nuclear Medicine Rush University Medical Center Chicago Illinois USA.
  • Bauer CE; Department of Neuroscience University of Kentucky Lexington Kentucky USA.
  • Kramer JH; Department of Neuroscience University of Kentucky Lexington Kentucky USA.
  • Staffaroni AM; Department of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California San Francisco California USA.
  • Stables L; Department of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California San Francisco California USA.
  • Wang DJJ; Department of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California San Francisco California USA.
  • Seshadri S; Laboratory of FMRI Technology (LOFT) Stevens Neuroimaging and Informatics Institute Keck School of Medicine University of Southern California Los Angeles California USA.
  • Satizabal CL; Department of Neurology Boston University School of Medicine Boston Massachusetts USA.
  • Beiser A; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases University of Texas Health San Antonio San Antonio Texas USA.
  • Habes M; Department of Neurology Boston University School of Medicine Boston Massachusetts USA.
  • Fornage M; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases University of Texas Health San Antonio San Antonio Texas USA.
  • Mosley TH; Department of Population Health Sciences University of Texas Health San Antonio San Antonio Texas USA.
  • Rosenberg GA; Department of Neurology Boston University School of Medicine Boston Massachusetts USA.
  • Singh B; Department of Biostatistics Boston University School of Public Health Boston Massachusetts USA.
  • Singh H; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases University of Texas Health San Antonio San Antonio Texas USA.
  • Schwab K; Brown Foundation Institute of Molecular Medicine McGovern Medical School School of Public Health The University of Texas Health Science Center at Houston Houston Texas USA.
  • Helmer KG; Human Genetics Center School of Public Health The University of Texas Health Science Center at Houston Houston Texas USA.
  • Greenberg SM; MIND Center University of Mississippi Medical Center Jackson Mississippi USA.
  • DeCarli C; Department of Neurology University of New Mexico Albuquerque New Mexico USA.
  • Caprihan A; Department of Neurology University of California Davis California USA.
Alzheimers Dement (Amst) ; 14(1): e12362, 2022.
Article in En | MEDLINE | ID: mdl-36523847
ABSTRACT

Introduction:

To evaluate the clinical validity of free water (FW), a diffusion tensor imaging-based biomarker kit proposed by the MarkVCID consortium, by investigating the association between mean FW (mFW) and executive function.

Methods:

Baseline mFW was related to a baseline composite measure of executive function (EFC), adjusting for relevant covariates, in three MarkVCID sub-cohorts, and replicated in five, large, independent legacy cohorts. In addition, we tested whether baseline mFW predicted accelerated EFC score decline (mean follow-up time 1.29 years).

Results:

Higher mFW was found to be associated with lower EFC scores in MarkVCID legacy and sub-cohorts (p-values < 0.05). In addition, higher baseline mFW was associated significantly with accelerated decline in EFC scores (p = 0.0026).

Discussion:

mFW is a sensitive biomarker of cognitive decline, providing a strong clinical rational for its use as a marker of white matter (WM) injury in multi-site observational studies and clinical trials of vascular cognitive impairment and dementia (VCID).
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Alzheimers Dement (Amst) Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Alzheimers Dement (Amst) Year: 2022 Document type: Article